Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) - ScienceDirect
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial - The Lancet
Pancreatic Cancer IO Landscape - Cancer Research Institute (CRI)
Treatment of Metastatic Pancreatic Adenocarcinoma: A Review
Treatment landscape of metastatic pancreatic cancer - Cancer Treatment Reviews
Metastatic Pancreatic Cancer: ASCO Guideline Update | Journal of Clinical Oncology
Clinical trials using targeted agents for advanced or metastatic... | Download Table
Clinical trials with MEK1/2 inhibitors in metastatic pancreatic cancer | Download Table
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial | PLOS ONE
Phase 1 Trials in Pancreatic Cancer
Current Standards and Novel Treatment Options for Metastatic Pancreatic Adenocarcinoma
Fluorouracil for Cancer of Pancreas Clinical Trial | Power
Cancers | Free Full-Text | Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis | HTML
Enrolling Clinical Trials: Combination Chemotherapy / Immunotherapy for Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma - Penn Medicine
Principal phase Ⅲ clinical trials involving targeted therapy in... | Download Table
New therapeutic targets in pancreatic cancer - Cancer Treatment Reviews
Therapeutic developments in pancreatic cancer: current and future perspectives | Nature Reviews Gastroenterology & Hepatology
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Frontiers | The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy | Oncology
Frontiers | Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma | Oncology
Metastatic Pancreatic Cancer: ASCO Guideline Update | Journal of Clinical Oncology
Olaparib for Pancreatic Cancer with BRCA Mutations - NCI
Clinical Studies in the Second Line Setting of Advanced Pancreatic Cancer: Are We Making Any Progress?
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors - European Journal of Cancer
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? | Oncotarget
Promising New Pancreatic Cancer Clinical Trial Now at Summit Cancer Centers
Emerging treatments for advanced pancreatic cancer: clinical potential | GICTT
